Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Rachel L Matz1, Ramaroson Andriantsitohaina

  • 1Biochemisches Institut, Fachbereich Humanmedizin, Justus Liebig Universität, Giessen, Germany.

Drugs & Aging
|May 17, 2003
PubMed
Summary

Aging impairs blood vessel dilation due to endothelial dysfunction, increasing cardiovascular risk in older adults. Restoring endothelial function may reverse these effects and aid in developing new therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation.

Biochemical pharmacology·2026
Same author

Primary cilia disruption reprograms extracellular vesicle signaling in endothelial dysfunction and cardiovascular disease.

Life sciences·2026
Same author

Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in <i>LMNA</i> Mutation-Induced Dilated Cardiomyopathy.

Circulation. Heart failure·2026
Same author

NLRP3, conveyed via extracellular vesicles from metabolic syndrome patients, is involved in atherosclerosis development.

Cell communication and signaling : CCS·2025
Same author

Hyperlipidemia and endothelial dysfunction: effects of eNOS phosphorylation and vascular ultrastructure in normoglycemic <i>Psammomys obesus</i>.

Ultrastructural pathology·2025
Same author

Provinols™, a Polyphenolic Extract of Red Wine, Inhibits In-Stent Neointimal Growth in Cholesterol-Fed Rabbit.

Pharmaceutics·2024

Area of Science:

  • Vascular Biology
  • Gerontology
  • Cardiovascular Medicine

Background:

  • Aging causes structural and functional vascular wall changes, including extracellular matrix, smooth muscle, and endothelial alterations.
  • Endothelial dysfunction, a reduced capacity for vasodilation, is a hallmark of aging, independent of other cardiovascular risk factors.
  • This age-related dysfunction contributes to increased cardiovascular events in the elderly, suggesting therapeutic potential in restoring endothelial function.

Purpose of the Study:

  • To understand the mechanisms and etiopathogenesis of age-related endothelial dysfunction.
  • To identify potential therapeutic targets for reversing endothelial dysfunction and mitigating cardiovascular risk in aging populations.

Main Methods:

  • The study reviews age-dependent alterations in endothelium-dependent relaxation in various arteries across species.

Related Experiment Videos

  • It examines the shift in the balance of endothelial relaxing and contracting factors during aging.
  • The role of specific signaling pathways, including nitric oxide, endothelium-derived hyperpolarizing factor, free radicals, prostanoids, endothelin-1, and angiotensin II, is discussed.

    • Main Results:

    • Aging leads to a reduced contribution of nitric oxide and endothelium-derived hyperpolarizing factor.
    • There is an increased involvement of oxygen-derived free radicals and cyclo-oxygenase-derived prostanoids in aged vasculature.
    • Age-related endothelial dysfunction involves alterations in endothelin-1 and angiotensin II signaling pathways.

    Conclusions:

    • Age-dependent endothelial dysfunction is a widespread phenomenon affecting vascular health.
    • Therapeutic strategies targeting signaling cascades, such as antioxidant therapy, lipid-lowering drugs, and estrogens, show promise.
    • Further understanding of these mechanisms is crucial for developing effective treatments for age-related cardiovascular diseases.